Hypoplastic right heart syndrome
ORPHA:98723Clinical groupNeonatal
Эпидемиология17
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Prevalence at birth | 1-9 / 100 000 | 3.3 | Europe | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 2.9 | Belgium | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 19.8 | Denmark | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 2 | France | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 5.8 | Germany | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 3.3 | Hungary | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 3.6 | Ireland | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 1.4 | Italy | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 24.1 | Malta | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 5.8 | Netherlands | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 6.5 | Norway | Value and class |
| Prevalence at birth | 1-9 / 1 000 000 | 0.5 | Poland | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 12.6 | Switzerland | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 3.9 | United Kingdom | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 9.5 | Ukraine | Value and class |
| Prevalence at birth | 1-9 / 1 000 000 | 0.6 | Spain | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 1.68 | United States | Value and class |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)